Short communicationRapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48 h after the start of treatment with pegylated interferon and ribavirin
Section snippets
Acknowledgments
Authors are grateful to Valentina Svicher and Maria Mercedes Santoro for their thoughtful contribution in statistical and data analysis, and to Loredana Puglielli, Angela Pisciella and Vincenzo Massei for helpful assistance with HCV-patients. Declaration of funding interests: Ennio Polilli, Elena Mazzotta and Francesco Di Masi were co-funded by research grants from the Fondazione Camillo de Lellis per l’Innovazione e la Ricerca in Medicina, Pescara, Italy. All other study costs were covered by
References (13)
- et al.
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy
Hepatology
(2003) - et al.
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study
Lancet
(2001) - et al.
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
J. Viral. Hepat.
(2009) - et al.
Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon
J. Med. Virol.
(2006) - et al.
Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment
Clin. Infect. Dis.
(2009) - et al.
Peginterferon and ribavirin for chronic hepatitis C
N. Engl. J. Med.
(2006)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2010 Elsevier B.V. All rights reserved.